Kappos L - Search Results

1

The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges.

Ghezzi A, Amato MP, Edan G, Hartung HP, Havrdová EK, Kappos L, Montalban X, Pozzilli C, Sorensen PS, Trojano M, Vermersch P, Comi G. Ghezzi A, et al. Among authors: kappos l. Mult Scler. 2021 Mar;27(3):479-482. doi: 10.1177/1352458520930620. Epub 2020 Jun 16. Mult Scler. 2021. PMID: 32539596 Clinical Trial.

2

[15+/-deoxyspergualin, hope for patients with multiple sclerosis?].

Kappos L, Theobald K, Hartung HP. Kappos L, et al. Nervenarzt. 1992 Dec;63(12):768-71; discussion 772. Nervenarzt. 1992. PMID: 1494394 Review. German. No abstract available.

3

Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis.

Kappos L, Städt D, Ratzka M, Keil W, Schneiderbanger-Grygier S, Heitzer T, Poser S, Nadjmi M. Kappos L, et al. Neuroradiology. 1988;30(4):299-302. doi: 10.1007/BF00328179. Neuroradiology. 1988. PMID: 3050587 Clinical Trial.

4

Clinical trials of immunosuppression and immunomodulation in multiple sclerosis.

Kappos L. Kappos L. J Neuroimmunol. 1988 Dec;20(2-3):261-8. doi: 10.1016/0165-5728(88)90173-7. J Neuroimmunol. 1988. PMID: 3058744 Clinical Trial.

5

Treatment of multiple sclerosis with 15 +/- deoxyspergualin. Design of a controlled study with close MRI-monitoring.

Kappos L, Radü EW, Bernasconi L, Brunnschweiler H, Hartung HP, Haas J, Gehlen W, Hartard C, Lagreze HL, Rüttinger H, et al. Kappos L, et al. Schweiz Arch Neurol Psychiatr (1985). 1993;144(3):198-201. Schweiz Arch Neurol Psychiatr (1985). 1993. PMID: 7687364 Clinical Trial.

6

Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trial.

Poehlau D, Federlein J, Postert T, Sailer M, Bethke F, Kappos L, Haas J, Przuntek H. Poehlau D, et al. Among authors: kappos l. Mult Scler. 1997 Apr;3(2):149-52. doi: 10.1177/135245859700300217. Mult Scler. 1997. PMID: 9291171 Clinical Trial.

7

Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.

Polman CH, Dahlke F, Thompson AJ, Ghazi M, Kappos L, Miltenburger C, Pozilli C. Polman CH, et al. Among authors: kappos l. Mult Scler. 1995;1 Suppl 1:S51-4. Mult Scler. 1995. PMID: 9345400 Clinical Trial.

8

Interferon beta in the treatment of multiple sclerosis--closing remarks.

Kappos L. Kappos L. Mult Scler. 1995;1 Suppl 1:S64-6. Mult Scler. 1995. PMID: 9345403 Review. No abstract available.

9

Combinations of drugs.

Kappos L. Kappos L. Mult Scler. 1996 Jul;1(6):400-3. doi: 10.1177/135245859600100624. Mult Scler. 1996. PMID: 9345426

10

Body fluid markers to monitor multiple sclerosis: the assays and the challenges.

Laman JD, Thompson EJ, Kappos L. Laman JD, et al. Among authors: kappos l. Mult Scler. 1998 Jun;4(3):266-9. doi: 10.1177/135245859800400334. Mult Scler. 1998. PMID: 9762687 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

810 results

Search Page

Filters